Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Structure-activity studies of RFamide-related peptide-1 identify a functional receptor antagonist and novel cardiac myocyte signaling pathway involved in contractile performance.

Nichols R, Bass C, Demers L, Larsen B, Li E, Blewett N, Converso-Baran K, Russell MW, Westfall MV.

J Med Chem. 2012 Sep 13;55(17):7736-45. doi: 10.1021/jm300760m. Epub 2012 Aug 30.

2.

Human RFamide-related peptide-1 diminishes cellular and integrated cardiac contractile performance.

Nichols R, Demers LA, Larsen BM, Robinson D, Converso K, Russell MW, Westfall MV.

Peptides. 2010 Nov;31(11):2067-74. doi: 10.1016/j.peptides.2010.07.012. Epub 2010 Aug 24.

3.

New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals.

Hinuma S, Shintani Y, Fukusumi S, Iijima N, Matsumoto Y, Hosoya M, Fujii R, Watanabe T, Kikuchi K, Terao Y, Yano T, Yamamoto T, Kawamata Y, Habata Y, Asada M, Kitada C, Kurokawa T, Onda H, Nishimura O, Tanaka M, Ibata Y, Fujino M.

Nat Cell Biol. 2000 Oct;2(10):703-8.

PMID:
11025660
4.

Protein kinase C depresses cardiac myocyte power output and attenuates myofilament responses induced by protein kinase A.

Hinken AC, Hanft LM, Scruggs SB, Sadayappan S, Robbins J, Solaro RJ, McDonald KS.

J Muscle Res Cell Motil. 2012 Dec;33(6):439-48. doi: 10.1007/s10974-012-9294-9. Epub 2012 Apr 22.

5.

Structure-activity and immunochemical data provide evidence of developmental- and tissue-specific myosuppressin signaling.

Dickerson M, McCormick J, Mispelon M, Paisley K, Nichols R.

Peptides. 2012 Aug;36(2):272-9. doi: 10.1016/j.peptides.2012.05.002. Epub 2012 May 18.

6.

PKCβII modulation of myocyte contractile performance.

Hwang H, Robinson DA, Stevenson TK, Wu HC, Kampert SE, Pagani FD, Dyke DB, Martin JL, Sadayappan S, Day SM, Westfall MV.

J Mol Cell Cardiol. 2012 Aug;53(2):176-86. doi: 10.1016/j.yjmcc.2012.05.001. Epub 2012 May 14.

7.

Independent modulation of contractile performance by cardiac troponin I Ser43 and Ser45 in the dynamic sarcomere.

Lang SE, Schwank J, Stevenson TK, Jensen MA, Westfall MV.

J Mol Cell Cardiol. 2015 Feb;79:264-74. doi: 10.1016/j.yjmcc.2014.11.022. Epub 2014 Dec 3.

8.

Intraamygdaloid microinjection of RFamide-related peptide-3 decreases food intake in rats.

Kovács A, László K, Gálosi R, Ollmann T, Péczely L, Zagoracz O, Bencze N, Lénárd L.

Brain Res Bull. 2014 Aug;107:61-8. doi: 10.1016/j.brainresbull.2014.07.002. Epub 2014 Jul 15.

PMID:
25048146
9.
10.

Evolutionary origin of GnIH and NPFF in chordates: insights from novel amphioxus RFamide peptides.

Osugi T, Okamura T, Son YL, Ohkubo M, Ubuka T, Henmi Y, Tsutsui K.

PLoS One. 2014 Jul 1;9(7):e100962. doi: 10.1371/journal.pone.0100962. eCollection 2014.

11.

Structure-activity studies of RFamide peptides reveal subtype-selective activation of neuropeptide FF1 and FF2 receptors.

Findeisen M, Rathmann D, Beck-Sickinger AG.

ChemMedChem. 2011 Jun 6;6(6):1081-93. doi: 10.1002/cmdc.201100089. Epub 2011 May 4.

PMID:
21548099
12.

Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium.

van der Velden J, Narolska NA, Lamberts RR, Boontje NM, Borbély A, Zaremba R, Bronzwaer JG, Papp Z, Jaquet K, Paulus WJ, Stienen GJ.

Cardiovasc Res. 2006 Mar 1;69(4):876-87. Epub 2005 Dec 27.

PMID:
16376870
13.

β-adrenergic effects on cardiac myofilaments and contraction in an integrated rabbit ventricular myocyte model.

Negroni JA, Morotti S, Lascano EC, Gomes AV, Grandi E, Puglisi JL, Bers DM.

J Mol Cell Cardiol. 2015 Apr;81:162-75. doi: 10.1016/j.yjmcc.2015.02.014. Epub 2015 Feb 25.

14.

Frequency-dependent myofilament Ca2+ desensitization in failing rat myocardium.

Lamberts RR, Hamdani N, Soekhoe TW, Boontje NM, Zaremba R, Walker LA, de Tombe PP, van der Velden J, Stienen GJ.

J Physiol. 2007 Jul 15;582(Pt 2):695-709. Epub 2007 May 3.

15.

The alpha(1)-adrenoceptor subtype- and protein kinase C isoform-dependence of Norepinephrine's actions in cardiomyocytes.

Rohde S, Sabri A, Kamasamudran R, Steinberg SF.

J Mol Cell Cardiol. 2000 Jul;32(7):1193-209.

PMID:
10860763
16.

A-kinase anchoring protein targeting of protein kinase A in the heart.

Ruehr ML, Russell MA, Bond M.

J Mol Cell Cardiol. 2004 Sep;37(3):653-65. Review.

PMID:
15350838
17.

Degradation of cardiac myosin light chain kinase by matrix metalloproteinase-2 contributes to myocardial contractile dysfunction during ischemia/reperfusion.

Gao L, Zheng YJ, Gu SS, Tan JL, Paul C, Wang YG, Yang HT.

J Mol Cell Cardiol. 2014 Dec;77:102-12. doi: 10.1016/j.yjmcc.2014.10.004. Epub 2014 Oct 18.

PMID:
25451385
18.

The cAMP binding protein Epac regulates cardiac myofilament function.

Cazorla O, Lucas A, Poirier F, Lacampagne A, Lezoualc'h F.

Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14144-9. doi: 10.1073/pnas.0812536106. Epub 2009 Aug 6.

19.

Myocardial adenosine A(1)-receptor-mediated adenoprotection involves phospholipase C, PKC-epsilon, and p38 MAPK, but not HSP27.

Fenton RA, Shea LG, Doddi C, Dobson JG Jr.

Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H1671-8. doi: 10.1152/ajpheart.01028.2009. Epub 2010 Apr 2.

20.

PKC-dependent coupling of calcium permeation through transient receptor potential canonical 3 (TRPC3) to calcineurin signaling in HL-1 myocytes.

Poteser M, Schleifer H, Lichtenegger M, Schernthaner M, Stockner T, Kappe CO, Glasnov TN, Romanin C, Groschner K.

Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10556-61. doi: 10.1073/pnas.1106183108. Epub 2011 Jun 8. Erratum in: Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13876-8.

Supplemental Content

Support Center